|
U.S. Patents Awarded to Inventors in California (Feb. 11)
(Targeted News Service Via Acquire Media NewsEdge) Targeted News Service
Targeted News Service
ALEXANDRIA, Va., Feb. 11 -- The following federal patents were awarded to inventors in California.
***
Carnegie Mellon University Assigned Patent
ALEXANDRIA, Va., Feb. 11 -- Carnegie Mellon University, Pittsburgh, has been assigned a patent (8,367,051) developed by five co-inventors for "preparation of functional gel particles with a dual crosslink network." The co-inventors are Krzysztof Matyjaszewski, Pittsburgh, Ke Min, Albany, Calif., Jung Kwon Oh, Midland, Mich., James Spanswick, Wheaton, Ill., and Nicolay V. Tsarevsky, Pittsburgh.
The abstract of the patent published by the U.S. Patent and Trademark Office states: "Functional gel particle formed from a crosslinked polymeric network including a fraction of stable crosslinks and a second fraction of cleavable crosslinks are disclosed. Functional compounds may be chemically or physically encapsulated within and/or released from the gel particle by selective cleavage of the cleavable crosslinks. The functional compounds may be delivered and released to a pre-selected target site. Peripheral or other accessible functionality on the surface of the gel particle allows attachment of a surface reactive agent, thereby modifying one or more surface properties of the gel particle. Processes of preparing the gel particles and processes of delivering the functional compounds to a target site are also disclosed."
The patent application was filed on Oct. 9, 2007 (12/311,673). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,367,051&OS=8,367,051&RS=8,367,051
Written by Arpi Sharma; edited by Anand Kumar.
***
Invention Science Fund I Assigned Patent
ALEXANDRIA, Va., Feb. 11 -- Invention Science Fund I, Bellevue, Wash., has been assigned a patent (8,367,003) developed by seven co-inventors for an "acoustically controlled reaction device." The co-inventors are Leroy E. Hood, Seattle, Muriel Y. Ishikawa, Livermore, Calif., Edward K.Y. Jung, Bellevue, Wash., Robert Langer, Newton, Mass., Clarence T. Tegreene, Bellevue, Wash., Lowell L. Wood Jr., Livermore, Calif., and Victoria Y.H. Wood, Livermore, Calif.
The abstract of the patent published by the U.S. Patent and Trademark Office states: "Embodiments of a system including a remotely controlled reaction device and associated controller are described. Methods of use and control of the device are also disclosed. According to various embodiments, a reaction device is placed in an environment in order to perform a chemical reaction in an environment. Exemplary environments include a body of an organism, a body of water, or an enclosed volume of a fluid. In selected embodiments, an acoustic control signal may be used."
The patent application was filed on Feb. 12, 2009 (12/378,419). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,367,003&OS=8,367,003&RS=8,367,003
Written by Arpi Sharma; edited by Anand Kumar.
***
Watkins Manufacturing Assigned Patent
ALEXANDRIA, Va., Feb. 11 -- Watkins Manufacturing, Vista, Calif., has been assigned a patent (8,366,922) developed by Michael McCague, Escondido, Calif., for an exchangeable media filter.
The abstract of the patent published by the U.S. Patent and Trademark Office states: "A filter element for a pool or spa including a sintered plastic outer cylinder of a first diameter, a sintered plastic inner cylinder of a second diameter less than said first diameter; the inner cylinder being position coaxially with respect to the outer cylinder to define an annular interior chamber; and a selected granulated filter medium or combination of media residing in the annular interior chamber."
The patent application was filed on April 19, 2010 (12/762,632). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,366,922&OS=8,366,922&RS=8,366,922
Written by Arpi Sharma; edited by Anand Kumar.
***
Cree Assigned Patent
ALEXANDRIA, Va., Feb. 11 -- Cree, Goleta, Calif., has been assigned a patent (8,366,830) developed by four co-inventors for a "susceptor apparatus for inverted type MOCVD reactor." The co-inventors are Shuji Nakamura, Santa Barbara, Calif., Steven DenBaars, Goleta, Calif., Max Batres, Santa Barbara, Calif., and Michael Coulter, Santa Barbara, Calif.
The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention discloses a susceptor mounting assembly for holding semiconductor wafers in an MOCVD reactor during growth of epitaxial layers on the wafers, that is particularly adapted for mounting a susceptor in an inverted type reactor chamber. It includes a tower having an upper and lower end with the upper end mounted to the top inside surface of the reactor chamber and a susceptor is arranged at the tower's lower end. Semiconductor wafers are held adjacent to the susceptor such that heat from the susceptor passes into wafers. A second embodiment of a susceptor mounting assembly according to the invention also comprises a tower having an upper and lower end. The tower's upper end is mounted to the top inside surface of the reactor chamber. A susceptor is housed within a cup and the cup is mounted to the tower's lower end."
The patent application was filed on March 4, 2003 (10/382,198). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,366,830&OS=8,366,830&RS=8,366,830
Written by Arpi Sharma; edited by Anand Kumar.
***
Caliper Life Sciences Assigned Patent
ALEXANDRIA, Va., Feb. 11 -- Caliper Life Sciences, Hopkinton, Mass., has been assigned a patent (8,367,021) developed by Colin B. Kennedy, Greenbrae, Calif., Josh Molho, Oakland, Calif., and Alexander V. Dukhovny, San Francisco, for "fluidic devices having incorporated electrodes."
The abstract of the patent published by the U.S. Patent and Trademark Office states: "The invention provides fluidic devices having incorporated electrodes. One device comprises a card and a caddy. The card includes a channel disposed within the card, first and second vias in fluid communication with the channel through an upper surface of the card, and first and second electrodes disposed on the upper surface of the card. The first via and first electrode are positioned adjacent to a first end of the channel, and the second via and second electrode are positioned adjacent to a second end of the channel. The caddy comprises first and second reservoirs. The caddy is attached to the card such that the first reservoir is positioned over the first via and a portion of the first electrode, and the second reservoir is positioned over the second via and a portion of the second electrode. A portion of each of the electrodes is accessible for dry electrical contact."
The patent application was filed on Feb. 18, 2011 (13/030,379). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,367,021&OS=8,367,021&RS=8,367,021
Written by Arpi Sharma; edited by Anand Kumar.
***
Kovio Assigned Patent
ALEXANDRIA, Va., Feb. 11 -- Kovio, San Jose, Calif., has been assigned a patent (8,367,031) developed by seven co-inventors for a "silane compositions, methods of making the same, method for forming a semiconducting and/or silicon-containing film, and thin film structures formed therefrom." The co-inventors are Klaus Kunze, Half Moon Bay, Calif., Wenzhuo Guo, Cupertino, Calif., Fabio Zurcher, Brisbane, Calif., Mao Takashima, Cupertino, Calif., Laila Francisco, El Dorado Hills, Calif., Joerg Rockenberger, Redwood City, Calif., and Brent Ridley, San Carlos, Calif.
The abstract of the patent published by the U.S. Patent and Trademark Office states: "A method of making hydrogenated Group IVA compounds having reduced metal-based impurities, compositions and inks including such Group IVA compounds, and methods for forming a semiconductor thin film. Thin semiconducting films prepared according to the present invention generally exhibit improved conductivity, film morphology and/or carrier mobility relative to an otherwise identical structure made by an identical process, but without the washing step. In addition, the properties of the present thin film are generally more predictable than those of films produced from similarly prepared (cyclo)silanes that have not been washed according to the present invention. The present invention advantageously provides semiconducting thin film structures having qualities suitable for use in electronics applications, such as display devices or RF ID tags, while enabling high-throughput manufacturing processes that form such thin films in seconds or minutes, rather than hours or days as with conventional photolithographic processes."
The patent application was filed on Jan. 13, 2012 (13/349,838). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,367,031&OS=8,367,031&RS=8,367,031
Written by Arpi Sharma; edited by Anand Kumar.
***
Applied Biosystems Assigned Patent
ALEXANDRIA, Va., Feb. 11 -- Applied Biosystems, Carlsbad, Calif., has been assigned a patent (8,366,900) developed by Karl O. Voss, Foster City, Calif., and Aldrich N.K. Lau, Palo Alto, Calif., for a "high speed, high resolution compositions, methods and kits for capillary electrophoresis."
The abstract of the patent published by the U.S. Patent and Trademark Office states: "The invention provides compositions, methods and kits for high speed, high resolution of analytes by capillary electrophoresis starting with uncoated capillaries. The compositions comprise a sieving component, comprising a non-crosslinked acrylamide polymer, and a surface interaction component, comprising at least one uncharged and non-crosslinked water-soluble silica-adsorbing polymer. Methods for employing the novel compositions in capillary electrophoresis are provided. Kits comprising the novel compositions for use in the novel methods are also provided."
The patent application was filed on March 16, 2010 (12/725,425). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,366,900&OS=8,366,900&RS=8,366,900
Written by Arpi Sharma; edited by Anand Kumar.
***
U.S. Army Assigned Patent
ALEXANDRIA, Va., Feb. 11 -- The U.S. Army has been assigned a patent (8,366,961) developed by four co-inventors for a "chemical combination for the generation of disinfectant and heat." The co-inventors are Christopher J. Doona, Marlborough, Mass., Maria Agudelo Curtin, Easton, Mass., Irwin A. Taub, Ashland, Mass., and Kenneth Kustin, San Diego.
The abstract of the patent published by the U.S. Patent and Trademark Office states: "This invention comprises a lightweight, portable chemical combination of reagents for sterilizing or disinfecting objects in the absence of electrical power or fire. The chemical combination includes a chemical oxidant with the capacity to liberate a biocidal intermediate, a chemical reductant of the oxidant with the capacity to react with the oxidant, and an effector to induce a reaction between the oxidant and reductant. In one embodiment, the oxidant comprises chlorite, the reductant comprises sulfite, and the effector comprises ascorbate. In another embodiment, the chemical combination comprises the oxidant, reductant, effector and iron-activated magnesium. When water or water solutions are added to either embodiment, the chemical combination generates heat, steam and a biocidal intermediate that can destroy contaminating microorganisms. In one embodiment, the biocidal intermediate is a halogen-based biocidal intermediate, such as chlorine dioxide. In another embodiment, the biocidal intermediate is a halogen-free biocidal intermediate."
The patent application was filed on Dec. 23, 2010 (12/977,133). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,366,961&OS=8,366,961&RS=8,366,961
Written by Arpi Sharma; edited by Anand Kumar.
***
L.M. Scofield Assigned Patent
ALEXANDRIA, Va., Feb. 11 -- L. M. Scofield, Los Angeles, has been assigned a patent (8,366,824) developed by five co-inventors for a "high SRI systems for cementitious applications." The co-inventors are Stanley G. Stratton, Hiram, Ga., Phillip J. Arnold, Huntington Beach, Calif., James K. Crawford, Atlanta, Pritam S. Dhaliwal, Upland, Calif., and Martin Ellis Wild, Marietta, Ga.
The abstract of the patent published by the U.S. Patent and Trademark Office states: "High SRI cementitious systems comprising integral concrete coloring admixtures, toppings, dry-shake hardeners, and other cementitious systems are provided. The high-SRI cementitious systems comprise one or more IR reflective pigments and other components to make-up the cementitious system, depending on the application. The high-SRI cementitious systems of the invention may be in the form of mixtures which increase the total solar reflectivity (TSR or albedo) and the Solar Reflectance Index (SRI) of concrete. The high-SRI cementitious systems may be toppings mixed with water for application to existing concrete surfaces, dry-shake hardeners for application to freshly-placed plastic concrete, or the IR reflective pigments may be mixed into integrally colored concrete in various forms, such as conventional cast-in-place concrete, lightweight concrete, pervious concrete and concrete building panels, pavers or masonry units. The topping and dry-shake hardener formulations of the invention may further comprise one or more of cementitious binder(s), graded aggregates, super-plasticizers, one or more pigments selected for improving infrared reflectivity and color composition, and/or optionally other additives, such as dry redispersible polymers or fillers to provide decorative and LEED compliant, highly durable (sustainable) concrete hardscapes and other decorative concrete."
The patent application was filed on Jan. 9, 2009 (12/373,507). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,366,824&OS=8,366,824&RS=8,366,824
Written by Arpi Sharma; edited by Anand Kumar.
***
Intel Assigned Patent
ALEXANDRIA, Va., Feb. 11 -- Intel, Santa Clara, Calif., has been assigned a patent (8,367,017) developed by Selena Chan, San Jose, Calif., Sunghoon Kwon, Albany, Calif., and Narayan Sundararajan, San Francisco, for "methods for uniform metal impregnation into a nanoporous material."
The abstract of the patent published by the U.S. Patent and Trademark Office states: "The methods, systems 400 and apparatus disclosed herein concern metal 150 impregnated porous substrates 110, 210. Certain embodiments of the invention concern methods for producing metal-coated porous silicon substrates 110, 210 that exhibit greatly improved uniformity and depth of penetration of metal 150 deposition. The increased uniformity and depth allow improved and more reproducible Raman detection of analytes. In exemplary embodiments of the invention, the methods may comprise oxidation of porous silicon 110, immersion in a metal salt solution 130, drying and thermal decomposition of the metal salt 140 to form a metal deposit 150. In other exemplary embodiments of the invention, the methods may comprise microfluidic impregnation of porous silicon substrates 210 with one or more metal salt solutions 130. Other embodiments of the invention concern apparatus and/or systems 400 for Raman detection of analytes, comprising metal-coated porous silicon substrates 110, 210 prepared by the disclosed methods."
The patent application was filed on Oct. 7, 2009 (12/575,369). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,367,017&OS=8,367,017&RS=8,367,017
Written by Arpi Sharma; edited by Anand Kumar.
***
Nanosolar Assigned Patent
ALEXANDRIA, Va., Feb. 11 -- Nanosolar, San Jose, Calif., has been assigned a patent (8,366,973) developed by Dong Yu, Fremont, Calif., Jacqueline Fidanza, San Francisco, and Brian M. Sager, Menlo Park, Calif., for a "solution-based fabrication of photovoltaic cell."
The abstract of the patent published by the U.S. Patent and Trademark Office states: "An ink for forming CIGS photovoltaic cell active layers is disclosed along with methods for making the ink, methods for making the active layers and a solar cell made with the active layer. The ink contains a mixture of nanoparticles of elements of groups IB, IIIA and (optionally) VIA. The particles are in a desired particle size range of between about 1 nm and about 500 nm in diameter, where a majority of the mass of the particles comprises particles ranging in size from no more than about 40% above or below an average particle size or, if the average particle size is less than about 5 nanometers, from no more than about 2 nanometers above or below the average particle size. The use of such ink avoids the need to expose the material to an H.sub.2Se gas during the construction of a photovoltaic cell and allows more uniform melting during film annealing, more uniform intermixing of nanoparticles, and allows higher quality absorber films to be formed."
The patent application was filed on Oct. 31, 2007 (11/933,357). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,366,973&OS=8,366,973&RS=8,366,973
Written by Arpi Sharma; edited by Anand Kumar.
***
Chevron USA Assigned Patent
ALEXANDRIA, Va., Feb. 11 -- Chevron USA, San Ramon, Calif., has been assigned a patent (8,366,909) developed by Stephen J. Miller, San Francisco, for "reforming process at low pressure."
The abstract of the patent published by the U.S. Patent and Trademark Office states: "Processes for reforming of naphtha feedstocks are described. Briefly, a two stage naphtha reforming process is described. The first stage uses a low acidity beta zeolite catalyst under relatively mild reforming conditions to form an effluent. This effluent is passed to a subsequent stage where further reforming occurs using a catalyst containing ZSM-5 zeolite. The second stage is run under mild reforming conditions. The low pressures employed in the reforming process described maximize liquid product yield by avoiding unwanted cracking reactions and production of light products."
The patent application was filed on Feb. 26, 2009 (12/393,912). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,366,909&OS=8,366,909&RS=8,366,909
Written by Arpi Sharma; edited by Anand Kumar.
***
Biovec Assigned Patent
ALEXANDRIA, Va., Feb. 11 -- Biovec, Chicago, has been assigned a patent (8,367,056) developed by Lakshman R. Sehgal, Monarch Beach, Calif., and Jonathan Wong, Palot Alto, Calif., for an "in vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors."
The abstract of the patent published by the U.S. Patent and Trademark Office states: "A method for treating a renal disease in a subject is disclosed. The method includes administering into a kidney of the subject with an effective amount of a gutless adenoviral vector containing a polynucleotide encoding a therapeutic agent. The gutless adenoviral vector contains the nucleotide sequence of SEQ ID NO:13 or SEQ ID NO:15 and expresses the therapeutic agent in a kidney tissue of the subject."
The patent application was filed on Feb. 8, 2011 (13/023,314). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,367,056&OS=8,367,056&RS=8,367,056
Written by Arpi Sharma; edited by Anand Kumar.
***
Boeing Assigned Patent
ALEXANDRIA, Va., Feb. 11 -- Boeing, Chicago, has been assigned a patent (8,366,848) developed by Chin H. Toh, Orange, Calif., and James E. Engel, Newport Beach, Calif., for a "thick doped adhesive tape to enhance backscatter X-ray detectability."
The abstract of the patent published by the U.S. Patent and Trademark Office states: "Doped adhesive tape is used during the manufacture of aircraft, including positioning marks, covering orifices from debris, allowing locations to be marked. Any doped adhesive tape inadvertently left in sub-assemblies during the manufacturing process can be detected using backscatter X-ray inspection technology. Detection is facilitated in one embodiment by making the tape thicker, to produce an increased mass density, and in another embodiment by adding a dopant comprising an element that is readily detected by the backscatter X-ray technology. The element can be iodine, and can be incorporated into the backing layer or the adhesive layer of the tape during manufacturing. The use of both thicker tape and a dopant can be used in combination to facilitate detection. If the doped adhesive tape is detected after components are assembled using a backscatter X-ray inspection device, then the doped adhesive tape is removed."
The patent application was filed on July 1, 2011 (13/174,911). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,366,848&OS=8,366,848&RS=8,366,848
Written by Arpi Sharma; edited by Anand Kumar.
***
Chen Assigned Patent
ALEXANDRIA, Va., Feb. 11 -- Chung-Yang Mike Chen, Irvine, Calif., has been assigned a patent (8,367,010) developed by Chung-Yang Mike Chen, Irvine, and Robert Desantis, Beverly Hills, Calif., for an "ozone device for deodorizing dresses."
The abstract of the patent published by the U.S. Patent and Trademark Office states: "An ozone device for deodorizing dresses within a closet, includes an ozone generator. The ozone generator includes a casing formed with first and second ventilation vents, an ozone producing element installed within the casing for generating ozone in order to deodorizing dresses within the closet, a circulating fan installed within the casing for circulating ozone generated by the ozone producing element, and a hanging unit projecting outward from the casing and adapted to be hung onto a suspension member. The closet is sleeved over and cooperates with the casing to define a sealed chamber so that dresses can be kept therein."
The patent application was filed on Feb. 11, 2010 (12/703,851). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,367,010&OS=8,367,010&RS=8,367,010
Written by Arpi Sharma; edited by Anand Kumar.
***
City of Long Beach Assigned Patent
ALEXANDRIA, Va., Feb. 11 -- City of Long Beach, Long Beach, Calif., has been assigned a patent (8,366,924) developed by Diem Xuan Vuong, San Clemente, Calif., for a "two stage nanofiltration seawater desalination system."
The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention is directed to a method and apparatus for desalinating seawater utilizing a two stage seawater desalination system, a first stage including at least one high performance nanofiltration membrane to receive seawater feed pressurized by a first stage pump sufficiently and to produce a first permeate, and a second stage including at least one high performance nanofiltration membrane to receive the first permeate pressurized by a second stage pump to between about 200 psi and about 300 psi to produce potable water."
The patent application was filed on Dec. 1, 2006 (11/607,158). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,366,924&OS=8,366,924&RS=8,366,924
Written by Arpi Sharma; edited by Anand Kumar.
***
Fluidigm Assigned Patent
ALEXANDRIA, Va., Feb. 11 -- Fluidigm, South San Francisco, Calif., has been assigned a patent (8,367,016) developed by six co-inventors for a "method and system for microfluidic device and imaging thereof." The co-inventors are Emerson Chueng Quan, South San Francisco, Calif., Colin Jon Taylor, Burlingame, Calif., Michael Lee, Lake Oswego, Ore., Christopher G. Ceasar, Sunnyvale, Calif., Greg Harris, Longmont, Colo., and Gang Sun, Cupertino, Calif.
The abstract of the patent published by the U.S. Patent and Trademark Office states: "A method for producing an image of an object within a chamber of a microfluidic device includes providing the microfluidic device having x, y, and z dimensions and a chamber depth center point located along the z dimension. The chamber depth center point is located a known z dimension distance from a fiducial marking embedded within the microfluidic device. The method also includes placing the microfluidic device within an imaging system that includes an optical device capable of detecting the fiducial marking. The optical device defines an optical path axially aligned with the z dimension and has a focal plane perpendicular to the optical path. When the focal plane is moved along the optical path, the fiducial marking is maximally detected when the focal plane is at the z depth in comparison to when the focal plane is not substantially in-plane with the z depth."
The patent application was filed on Jan. 27, 2012 (13/360,591). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,367,016&OS=8,367,016&RS=8,367,016
Written by Arpi Sharma; edited by Anand Kumar.
***
Portola Pharmaceuticals Assigned Patent
ALEXANDRIA, Va., Feb. 11 -- Portola Pharmaceuticals, South San Francisco, Calif., has been assigned a patent (8,367,689) developed by seven co-inventors for inhibitors of JAK. The co-inventors are Shawn M. Bauer, Pacifica, Calif., Jack W. Rose, San Mateo, Calif., Yonghong Song, Foster City, Calif., Qing Xu, Foster City, Calif., Mukund Mehrotra, South San Francisco, Calif., Wolin Huang, Foster City, Calif., and Anjali Pandey, Fremont, Calif.
The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention is directed to compounds of formula I and tautomers and pharmaceutically acceptable salts thereof which are selective inhibitors of JAK. The present invention is also directed to intermediates used in making such compounds, the preparation of such a compound, pharmaceutical compositions containing such a compound, methods of inhibition JAK activity, and methods to prevent or treat a number of conditions mediated at least in part by JAK activity."
The patent application was filed on May 6, 2010 (12/775,358). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,67,689.PN.&OS=PN/83,67,689&RS=PN/83,67,689
Written by Amal Ahmed; edited by Jaya Anand.
***
Pacific Biosciences of California Assigned Patent
ALEXANDRIA, Va., Feb. 11 -- Pacific Biosciences of California, Menlo Park, Calif., has been assigned a patent (8,367,813) developed by Jonas Korlach, Castro Valley, Calif., for "phospholink nucleotides for sequencing applications."
The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention provides labeled phospholink nucleotides that can be used in place of naturally occurring nucleotide triphosphates or other analogs in template directed nucleic acid synthesis reactions and other nucleic acid reactions and various analyzes based thereon, including DNA sequencing, single base identification, hybridization assays, and others."
The patent application was filed on Nov. 17, 2009 (12/620,293). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,67,813.PN.&OS=PN/83,67,813&RS=PN/83,67,813
Written by Amal Ahmed; edited by Jaya Anand.
***
University of California Assigned Patent
ALEXANDRIA, Va., Feb. 11 -- The University of California, Oakland, Calif., has been assigned a patent (8,367,798) developed by Yang Yang, Los Angeles, and Jianhui Hou, Los Angeles, for "active materials for photoelectric devices and devices that use the materials."
The abstract of the patent published by the U.S. Patent and Trademark Office states: "A conjugated polymer has a repeated unit having the structure of formula (I) ##STR00001## wherein A1, A2, R1 and R2 are independently selected from the group consisting of a proton, an alkyl group comprising up to 18 carbon atoms, an alkoxy group comprising up to 18 carbon atoms, cyano, nitro, aryls and substituted aryls, and wherein Ar is selected from the group consisting of ethenylene, ethynylene, monocyclic arylene, bicyclic arylene, polycyclic arylene, monocyclic heteroarylene, bicyclic heteroarylene, polycyclic heteroarylene, and one to five such groups one of fused or linked."
The patent application was filed on Sept. 29, 2008 (12/240,334). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,67,798.PN.&OS=PN/83,67,798&RS=PN/83,67,798
Written by Amal Ahmed; edited by Jaya Anand.
***
Cylene Pharmaceuticals Assigned Patent
ALEXANDRIA, Va., Feb. 11 -- Cylene Pharmaceuticals, San Diego, has been assigned a patent (8,367,681) developed by Mustapha Haddach, San Diego, and Joe Tran, San Marcos, Calif., for "pyrazolopyrimidines and related heterocycles as kinase inhibitors."
The abstract of the patent published by the U.S. Patent and Trademark Office states: "The invention provides compounds of general formula (I) that inhibit selected kinases (Pim and/or CK2 kinases) and compositions containing such compounds. These compounds and compositions are useful for treating proliferative disorders such as cancer, as well as other kinase-associated conditions including inflammation, pain, and certain infections and immunological disorders. ##STR00001##."
The patent application was filed on May 20, 2010 (12/784,271). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,67,681.PN.&OS=PN/83,67,681&RS=PN/83,67,681
Written by Amal Ahmed; edited by Jaya Anand.
***
Xencor Assigned Patent
ALEXANDRIA, Va., Feb. 11 -- Xencor, Monrovia, Calif., has been assigned a patent (8,367,805) developed by five co-inventors for "Fc variants with altered binding to FcRn." The co-inventors are Aaron Keith Chamberlain, Pasadena, Calif., Bassil I. Dahiyat, Altadena, Calif., John R. Desjarlais, Pasadena, Calif., Sher Bahadur Karki, Pomona, Calif., and Gregory Alan Lazar, Arcadia, Calif.
The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present application relates to a variant Fc region comprising at least one modification relative to a wild-type human Fc region, where the modification selected from the group consisting of 434S, 252Y/428L, 252Y/434S, and 428L/434S, and the numbering is according to the EU index."
The patent application was filed on Dec. 22, 2008 (12/341,769). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,67,805.PN.&OS=PN/83,67,805&RS=PN/83,67,805
Written by Amal Ahmed; edited by Jaya Anand.
***
Amgen Assigned Patent
ALEXANDRIA, Va., Feb. 11 -- Amgen, Thousand Oaks, Calif., has been assigned a patent (8,367,671) developed by Andrew Tasker, Simi Valley, Calif., Liping H. Pettus, Thousand Oaks, Calif., and Ryan Wurz, Newbury Park, Calif., for "pyrazolo[3.4-B]pyrazine compounds as p38 modulators and methods of use as anti-inflamatory agents."
The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention comprises a new class of compounds useful for the prophylaxis and treatment of protein kinase mediated diseases, including inflammation and related conditions. The compounds have a general Formula I ##STR00001## wherein A.sup.1, B, R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5 and n are defined herein. The invention also comprises pharmaceutical compositions including one or more compounds of Formula I, uses of such compounds and compositions for treatment of p38 map kinase mediated diseases including rheumatoid arthritis, psoriasis, chronic obstructive pulmonary disease, pain and other inflammatory disorders, as well as intermediates and processes useful for the preparation of compounds of Formula I."
The patent application was filed on March 19, 2009 (12/933,406). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,67,671.PN.&OS=PN/83,67,671&RS=PN/83,67,671
Written by Amal Ahmed; edited by Jaya Anand.
***
Amyris Assigned Patent
ALEXANDRIA, Va., Feb. 11 -- Amyris, Emeryvillle, Calif., has been assigned a patent (8,367,859) developed by five co-inventors for cyclohexane 1,4 carboxylates. The co-inventors are John W. Frost, Okemos, Mich., Adeline Miermont, Toledo, Ohio, Dirk Schweitzer, Okemos, Mich., Vu Bui, Davis, Calif., and Douglas A. Wicks, Minneapolis.
The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention relates to cyclohexanes having carboxylate derivatives at the 1 and 4, and optionally the 2, position. The invention also relates to processes for preparing such compounds wherein a portion of the starting materials utililzed is derived from renewable resources."
The patent application was filed on June 16, 2010 (12/816,742). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,67,859.PN.&OS=PN/83,67,859&RS=PN/83,67,859
Written by Amal Ahmed; edited by Jaya Anand.
***
Vertex Pharmaceuticals, MSD Assigned Patent
ALEXANDRIA, Va., Feb. 11 -- Vertex Pharmaceuticals, Cambridge, Mass., and MSD, Tokyo, have been assigned a patent (8,367,690) developed by five co-inventors for "aminopyridine derivatives having aurora a selective inhibitory action." The co-inventors are Hayley Binch, Encinitas, Calif., Masaya Hashimoto, Tsukuba, Japan, Michael Mortimore, Abington, United Kingdom, Mitsuru Ohkubo, Ushiku, Japan, and Tomoko Sunami, Tokai-mura, Japan.
The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention relates to a compound of Formula (I): wherein: R.sup.1 is H, --NHCOOR.sup.1a, C.sub.5-6 cycloalkyl, or phenyl; where the cycloalkyl and phenyl each independently may be substituted with one to three of the same or different substituents selected from R.sup.10; R.sup.1a is C.sub.1-3 alkyl which may be substituted with one to three of the same or different substituents selected from F and Cl; R.sup.2 is H, --COOH, --CH.sub.2 COOH, --COOR.sup.2a, or --CH.sub.2COOR.sup.2a; R.sup.2a is C.sub.1-2 alkyl, where the alkyl may be substituted with one to three of the same or different substituents selected from halogen atoms; R.sup.3 is H, C.sub.1-6 alkyl, where the alkyl may be substituted with one to three of the same or different substituents selected from R.sup.11; R.sup.10 is F, Cl, CF.sub.3, or C.sub.1-2 alkyl; R.sup.11 is halogen atom, hydroxy, or cyano; W is selected from: W.sup.2a is H, halogen atom, cyano, C.sub.1-2 alkyl, or C.sub.3-5 cycloalkyl, or a pharmaceutically acceptable salt or ester thereof. ##STR00001##."
The patent application was filed on March 15, 2010 (13/259,620). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,67,690.PN.&OS=PN/83,67,690&RS=PN/83,67,690
Written by Amal Ahmed; edited by Jaya Anand.
***
Medtronic Vascular Assigned Patent
ALEXANDRIA, Va., Feb. 11 -- Medtronic Vascular, Santa Rosa, Calif., has been assigned a patent (8,366,765) developed by five co-inventors for a "helical stent with connections." The co-inventors are Matthew Baldwin, Santa Rosa, Calif., Richard Bliss, Cloverdale, Calif., Justin Goshgarian, Santa Rosa, Calif., Mark Hoff, Windsor, Calif., and Rui Lam, Santa Rosa, Calif.
The abstract of the patent published by the U.S. Patent and Trademark Office states: "A stent includes a continuous wave form wrapped around a longitudinal axis of the stent at a first pitch angle to define a first helix comprising a plurality of turns. The wave form includes a plurality of struts and a plurality of crowns. Each crown connects adjacent struts within a turn to define the continuous wave form. The stent also includes a plurality of connections configured to connect selected crowns of adjacent turns so that when the stent is in an unexpanded condition, the plurality of connections are aligned at a second pitch angle to define a second helix, and when the stent is in an expanded condition, at least some of the connections align along a substantially straight line parallel to the longitudinal axis of the stent."
The patent application was filed on Jan. 26, 2010 (12/693,585). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,366,765&OS=8,366,765&RS=8,366,765
Written by Arpi Sharma; edited by Anand Kumar.
***
3D Systems Assigned Patent
ALEXANDRIA, Va., Feb. 11 -- 3D Systems, Rock Hill, S.C., has been assigned a patent (8,366,789) developed by Scott Summit, San Francisco, for a prosthetic limb.
The abstract of the patent published by the U.S. Patent and Trademark Office states: "A prosthetic limb has an outer surface that is a mirror image of an intact limb or a generic limb design. The intact limb is scanned and the surface data is manipulated to create a virtual mirror image. If generic data is used, the intact leg can be measured and the generic surface can be adjusted so the prosthetic limb appears similar to the intact limb. The end of the amputated limb is also measured to obtain socket data. A knee and foot are incorporated to form a virtual prosthetic limb represented by design data. The design data for the virtual prosthetic limb is forwarded to a rapid prototyping machine that fabricates the entire leg simultaneously. Once completed, the prosthetic limb is shipped to the patient."
The patent application was filed on May 28, 2008 (12/128,378). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,366,789&OS=8,366,789&RS=8,366,789
Written by Arpi Sharma; edited by Anand Kumar.
***
Hamilton Sundstrand Assigned Patent
ALEXANDRIA, Va., Feb. 11 -- Hamilton Sundstrand, Windsor Locks, Conn., has been assigned a patent (8,366,809) developed by Michael J. Rollins, Chula Vista, Calif., and Melissa A. Bell, San Diego, for a deaerating method and assembly.
The abstract of the patent published by the U.S. Patent and Trademark Office states: "An example deaerator assembly includes a deaerating member disposed within a housing. The deaerating member includes an apertured stem extending from a pedestal. The apertured stem is configured to communicate air away from a mixture of air and coolant when the mixture of air and coolant is communicated about the apertured stem."
The patent application was filed on May 2, 2011 (13/099,320). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,366,809&OS=8,366,809&RS=8,366,809
Written by Arpi Sharma; edited by Anand Kumar.
***
Benvenue Medical Assigned Patent
ALEXANDRIA, Va., Feb. 11 -- Benvenue Medical, Santa Clara, Calif., has been assigned a patent (8,366,773) developed by Laurent Schaller, Los Altos, Calif., and Steven Golden, Menlo Park, Calif., for an "apparatus and method for treating bone."
The abstract of the patent published by the U.S. Patent and Trademark Office states: "A bone tamp for creating channels within bone tissue. The bone tamp includes an elongated member that is deformable from a first generally non-linear configuration to a second generally linear configuration for insertion into bone tissue. As the elongated member is deployed into bone tissue, it transitions from the linear configuration into the non-linear configuration within the bone tissue. The elongated member is capable of being deformed back into the generally linear configuration for withdrawal from the bone tissue."
The patent application was filed on Jan. 25, 2008 (12/020,396). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,366,773&OS=8,366,773&RS=8,366,773
Written by Arpi Sharma; edited by Anand Kumar.
***
Boeing Assigned Patent
ALEXANDRIA, Va., Feb. 11 -- Boeing, Chicago, has been assigned a patent (8,367,791) developed by Norman R. Byrd, Villa Park, Calif., and Douglas G. Soden, San Pedro, Calif., for a "composition and method for corrosion protection of a structure."
The abstract of the patent published by the U.S. Patent and Trademark Office states: "A method and composition for corrosion protection of a structure is provided. In one disclosed embodiment, a polysiloxane ureide which inhibits corrosion formation on a surface of a physical object is provided. The polysiloxane ureide has a backbone including, (i) at least one diamine-terminated polysiloxane as disclosed; (ii) at least one aromatic diamine; and, (iii) at least one diisocyanate. In another disclosed embodiment, there is provided a polyureide which inhibits corrosion formation on a surface of a physical object. The polyureide comprises: (i) at least one aliphatic diamine; (ii) at least one aromatic diamine; and, (iii) at least one diisocyanate."
The patent application was filed on Feb. 6, 2011 (13/021,782). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,67,791.PN.&OS=PN/83,67,791&RS=PN/83,67,791
Written by Amal Ahmed; edited by Jaya Anand.
***
Cool Planet Biofuels Assigned Patent
ALEXANDRIA, Va., Feb. 11 -- Cool Planet Biofuels, Camarillo, Calif., has been assigned a patent (8,367,881) developed by Michael Cheiky, Thousand Oaks, Calif., and Ronald A. Sills, Houston, for a "method for biomass fractioning by enhancing biomass thermal conductivity."
The abstract of the patent published by the U.S. Patent and Trademark Office states: "A method is described for generating useful chemical intermediates from biomass using a novel pyrolysis reactor that utilizes the inherent thermal properties of carbon under compression as the biomass is subjected to sequential or concurrent temperature ramps. The ramps are sufficient to volatilize and selectively create different components, while the pressure application aids the selective decomposition of the biomass."
The patent application was filed on May 9, 2011 (13/103,905). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,67,881.PN.&OS=PN/83,67,881&RS=PN/83,67,881
Written by Amal Ahmed; edited by Jaya Anand.
***
Inogen Assigned Patent
ALEXANDRIA, Va., Feb. 11 -- Inogen, Goleta, Calif., has been assigned a patent (8,366,815) developed by four co-inventors for an "advanced portable oxygen concentrator." The co-inventors are Brenton Taylor, Kenwood, Calif., Peter Hansen, Santa Barbara, Calif., John Stump, Santa Barbara, Calif., and Patrick Burgess, Dunedin, Fla.
The abstract of the patent published by the U.S. Patent and Trademark Office states: "A portable oxygen concentrator designed for medical use with a novel housing and internal component design that reduces noise and vibration while increasing durability. The improved design of the portable oxygen concentrator further facilitates easy maintenance and repair over the life of the equipment."
The patent application was filed on April 29, 2011 (13/066,984). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,366,815&OS=8,366,815&RS=8,366,815
Written by Arpi Sharma; edited by Anand Kumar.
***
Glykon Technologies Group Assigned Patent
ALEXANDRIA, Va., Feb. 11 -- Glykon Technologies Group, Las Vegas, has been assigned a patent (8,367,864) developed by Alex Moffett, Chatsworth, Calif., and Parag Shah, Jayanagar, India, for "dimeric double metal salts of (-)-hydroxycitric acid, methods of making and uses of same."
The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention relates to soluble dimeric double metal salt compositions of (-)-hydroxycitric acid ("HCA"), as well as methods for making and using the same. The invention provides dimeric double metal salts of group IA and IIA of HCA (hereinafter, "DDM-HCAs"). The present invention provides methods to make DDM-HCAs of the invention which can be employed to alter the polar/ionic qualities of HCA salts and derivatives to improve solubility of HCA compositions. DDM-HCAs of the invention are soluble HCA-containing compositions useful as dietary supplements and suitable for manipulations under those conditions necessary for tabletting, encapsulation, and the production of dry powders, particularly for use as a beverage premix. Methods of use of the composition include treatment for suppression of appetite, for weight loss, for an increase in the rate of fat metabolism, for reduction in blood lipids and postprandial lipemia, and to increase the plasma level of (-)-hydroxycitric acid."
The patent application was filed on Jan. 27, 2010 (12/694,828). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,67,864.PN.&OS=PN/83,67,864&RS=PN/83,67,864
Written by Amal Ahmed; edited by Jaya Anand.
***
Universite de Strasbourg, Northwestern University, Centre National de la Recherche Scientifique Assigned Patent
ALEXANDRIA, Va., Feb. 11 -- Universite de Strasbourg, Strasbourg, France, Northwestern University, Evanston, Ill., and Centre National de la Recherche Scientifique (CNRS), Paris, have been assigned a patent (8,367,672) developed by eight co-inventors for "pyridazine compounds, compositions and methods." The co-inventors are D. Martin Watterson, Chicago, Linda J. Van Eldik, Chicago, Jacques Haiech, Strasbourg, France, Marcel Hibert, Eschau, France, Jean-Jacques Bourguignon, Illkirch, France, Anastasia Velentza, San Diego, Wenhui Hu, Guangzhou, Switzerland, and Magdalena Zasadzki, Chicago.
The abstract of the patent published by the U.S. Patent and Trademark Office states: "The invention relates to novel chemical compounds and methods of making and using the same. In particular, the invention provides pyridazine compounds and/or related heterocyclic derivatives, compositions comprising the same, and methods of using pyridazine compounds and/or related heterocyclic derivatives and compositions comprising the same, for modulation of cellular pathways (e.g., signal transduction pathways), for treatment or prevention of inflammatory diseases (e.g., Alzheimer's disease), for research, drug screening, and therapeutic applications."
The patent application was filed on Nov. 2, 2005 (11/666,803). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,67,672.PN.&OS=PN/83,67,672&RS=PN/83,67,672
Written by Amal Ahmed; edited by Jaya Anand.
***
UOP Assigned Patent
ALEXANDRIA, Va., Feb. 11 -- UOP, Des Plaines, Ill., has been assigned a patent (8,366,804) developed by five co-inventors for a "high permeance polyimide membranes for air separation." The co-inventors are Chunqing Liu, Schaumburg, Ill., Raisa Minkov, Skokie, Ill., Syed A. Faheem, Huntley, Ill., Travis C. Bowen, Crystal Lake, Ill., and Jeffrey J. Chiou, Irvine, Calif.
The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention discloses a new type of polyimide membranes including hollow fiber and flat sheet membranes with high permeances for air separations and a method of making these membranes. The new polyimide hollow fiber membranes have O.sub.2 permeance higher than 300 GPU and O.sub.2/N.sub.2 selectivity higher than 3 at 60.degree. C. under 308 kPa for O.sub.2/N.sub.2 separation. The new polyimide hollow fiber membranes also have CO.sub.2 permeance higher than 1000 GPU and single-gas selectivity for CO.sub.2/CH.sub.4 higher than 20 at 50.degree. C. under 791 kPa for CO.sub.2/CH.sub.4 separation."
The patent application was filed on May 28, 2010 (12/790,095). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,366,804&OS=8,366,804&RS=8,366,804
Written by Arpi Sharma; edited by Anand Kumar.
***
Theken Spine Assigned Patent
ALEXANDRIA, Va., Feb. 11 -- Theken Spine, Akron, Ohio, has been assigned a patent (8,366,774) developed by four co-inventors for a "spinal cage having deployable member." The co-inventors are James Bruffey, San Diego, Eric A. Lab, Wadsworth, Ohio, Bret Everette Hartzell, Canton, Ohio, and Adam C. Sclafani, Uniontown, Ohio.
The abstract of the patent published by the U.S. Patent and Trademark Office states: "A spinal cage with a wall extending in a longitudinal direction defining an interior space is disclosed. There is also provided a deployable element in movable relation to the spinal cage."
The patent application was filed on Feb. 10, 2009 (12/368,890). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,366,774&OS=8,366,774&RS=8,366,774
Written by Arpi Sharma; edited by Anand Kumar.
***
International Business Machines, Stanford University Assigned Patent
ALEXANDRIA, Va., Feb. 11 -- International Business Machines, Armonk, N.Y., and Stanford University, Stanford, Calif., have been assigned a patent (8,367,796) developed by James Lupton Hedrick, Pleasanton, Calif., Russell Clayton Pratt, Oakland, Calif., and Robert M. Waymouth, Palo Alto, Calif., for a "catalytic polymerization of polymers containing electrophilic linkages using nucleophilic reagents."
The abstract of the patent published by the U.S. Patent and Trademark Office states: "The disclosure relates to methods and materials useful for polymerizing a monomer. In one embodiment, for example, the disclosure provides a method for polymerizing a monomer containing a plurality of electrophilic groups, wherein the method comprises contacting the monomer with a nucleophilic reagent in the presence of a guanidine-containing catalyst. The methods and materials of the disclosure find utility, for example, in the field of materials science."
The patent application was filed on July 1, 2009 (12/496,535). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,67,796.PN.&OS=PN/83,67,796&RS=PN/83,67,796
Written by Amal Ahmed; edited by Jaya Anand.
***
Range Fuels Assigned Patent
ALEXANDRIA, Va., Feb. 11 -- Range Fuels, Denver, has been assigned a patent (8,366,796) developed by Mitchell Mandich, Palo Alto, Calif., and William B. Schafer III, Boulder, Colo., for a "modular and distributed methods and systems to convert biomass to syngas."
The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention provides modular and distributed methods and systems to convert biomass feedstocks into synthesis gas (syngas). The syngas can then be turned into liquid chemicals and fuels such as ethanol. The modular units of the invention bring the conversion process to the biomass source, thereby minimizing feedstock transportation costs. The modules are capable of being connected to, and/or disconnected from, each other to easily adjust the overall feedstock capacity. The present invention also provides methods and systems to determine an optimal number and distribution of modular conversion units spatially located within a region of land. The disclosed methods and systems are flexible, efficient, scalable, and are capable of being cost-effective at any commercial scale of operation."
The patent application was filed on July 1, 2008 (12/166,117). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,366,796&OS=8,366,796&RS=8,366,796
Written by Arpi Sharma; edited by Anand Kumar.
***
SARcode Bioscience Assigned Patent
ALEXANDRIA, Va., Feb. 11 -- SARcode Bioscience, Brisbane, Calif., has been assigned a patent (8,367,701) developed by John Burnier, Pacifica, Calif., Thomas Gadek, Oakland, Calif., and Frederic Naud, Binningen, Switzerland, for a "crystalline pharmaceutical and methods of preparation and use thereof."
The abstract of the patent published by the U.S. Patent and Trademark Office states: "Novel crystalline polymorphic forms, Forms A, B, C, D, and E of a compound of Formula I, which has been found to be a potent inhibitor of LFA-1, are disclosed. Methods of preparation and uses thereof in the treatment of LFA-1 mediated diseases are also disclosed in this invention. ##STR00001##."
The patent application was filed on Nov. 4, 2011 (13/289,172). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,67,701.PN.&OS=PN/83,67,701&RS=PN/83,67,701
Written by Amal Ahmed; edited by Jaya Anand.
***
Elan Pharmaceuticals, Wyeth Assigned Patent
ALEXANDRIA, Va., Feb. 11 -- Elan Pharmaceuticals, South San Francisco, Calif., and Wyeth, Madison, N.J., have been assigned a patent (8,367,688) developed by seven co-inventors for "carbamate compounds which inhibit leukocyte adhesion mediated by VLA-4." The co-inventors are Christopher Michael Semko, Fremont, Calif., Ying-Zi Xu, Palo Alto, Calif., Frank Stappenbeck, Seattle, Jenifer Lea Smith, South San Francisco, Calif., Kassandra Inez Rossiter, San Jose, Calif., Juri Y. Fukuda, Oakland, Calif., and Andrei W. Konradi, Burlingame, Calif.
The abstract of the patent published by the U.S. Patent and Trademark Office states: "Disclosed are compounds which bind VLA-4. Certain of these compounds also inhibit leukocyte adhesion and, in particular, leukocyte adhesion mediated by VLA-4. Such compounds are useful in the treatment of inflammatory diseases in a mammalian patient, e.g., human, such as asthma, Alzheimer's disease, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, tissue transplantation, tumor metastasis and myocardial ischemia. The compounds can also be administered for the treatment of inflammatory brain diseases such as multiple sclerosis."
The patent application was filed on April 13, 2010 (12/759,419). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,67,688.PN.&OS=PN/83,67,688&RS=PN/83,67,688
Written by Amal Ahmed; edited by Jaya Anand.
***
California Institute of Technology Assigned Patent
ALEXANDRIA, Va., Feb. 11 -- California Institute of Technology, Pasadena, Calif., has been assigned a patent (8,367,815) developed by Christina D. Smolke, Pasadena, Calif., Maung Nyan Win, San Gabriel, Calif., and Chase L. Beisel, Pasadena, Calif., for "modular polynucleotides for ligand-controlled regulatory systems."
The abstract of the patent published by the U.S. Patent and Trademark Office states: "The invention provides an improved design for the construction of extensible nucleic acid-based, ligand-controlled regulatory systems, and the nucleic acid regulatory systems resulting therefrom. The invention contemplates improving the design of the switches (ligand-controlled regulatory systems) through the design of an information transmission domain (ITD). The improved ITD eliminates free-floating ends of the switching and the competing strands, and localizes competitive hybridization events to a contiguous strand of competing and switching strands in a strand-displacement mechanism-based switch, thereby improving the kinetics of strand-displacement. The improved regulatory systems have many uses in various biological systems, including gene expression control or ligand-concentration sensing."
The patent application was filed on Sept. 18, 2008 (12/284,154). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,67,815.PN.&OS=PN/83,67,815&RS=PN/83,67,815
Written by Amal Ahmed; edited by Jaya Anand.
***
Quest Diagnostics Investments Assigned Patent
ALEXANDRIA, Va., Feb. 11 -- Quest Diagnostics Investments, Wilmington, Del., has been assigned a patent (8,367,814) developed by Richard W. Tseng, Mission Viejo, Calif., and Michael K. Samoszuk, Rancho Santa Margarita, Calif., for an "assay for BCR/ABL gene rearrangement."
The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention provides a simple high-throughput assay for detecting bcr/abl translocations. The method includes qualitative PCR methods for identifying the particular amplified translocation (e1a2 or b2a3/b3a2) and real time PCR for quantifying an amount of bcr/abl transcript (e1a2, b2a3 and b3a2). Quantitative measurement of bcr/abl transcript in accordance with the methods of the invention is useful for monitoring response to therapy."
The patent application was filed on Dec. 9, 2009 (12/634,532). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,67,814.PN.&OS=PN/83,67,814&RS=PN/83,67,814
Written by Amal Ahmed; edited by Jaya Anand.
***
Creative Nail Design Assigned Patent
ALEXANDRIA, Va., Feb. 11 -- Creative Nail Design, Vista, Calif., has been assigned a patent (8,367,742) developed by four co-inventors for a "removable color layer for artificial nail coatings and methods therefore." The co-inventors are Thong H. Vu, Vista, Calif., Diane Marie Larsen, Carlsbad, Calif., Chad Conger, San Marcos, Calif., and Douglas D. Schoon, Dana Point, Calif.
The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present disclosure relates to a nail coating system comprising a basecoat, a color layer, and a topcoat. The system of the present disclosure may be applied to natural and/or pre-existing artificial nail coatings. The present disclosure relates generally to compositions for natural and artificial nail coatings, and particularly, but not by way of limitation, to polymerizable compositions and color layers polymerized therefrom. The disclosure further relates to methods of making a polymerized color layer."
The patent application was filed on Nov. 23, 2011 (13/303,584). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,67,742.PN.&OS=PN/83,67,742&RS=PN/83,67,742
Written by Amal Ahmed; edited by Jaya Anand.
***
ConforMIS Assigned Patent
ALEXANDRIA, Va., Feb. 11 -- ConforMIS, Bedford, Mass., has been assigned a patent (8,366,771) developed by six co-inventors for a "surgical tools facilitating increased accuracy, speed and simplicity in performing joint arthroplasty." The co-inventors are Albert G. Burdulis Jr., San Francisco, Wolfgang Fitz, Sheborn, Mass., Rene Vargas-Voracek, Sunnyvale, Calif., Philipp Lang, Lexington, Mass., Daniel Steines, Lexington, Mass., and Konstantinos Tsougarakis, Sunnyvale, Calif.
The abstract of the patent published by the U.S. Patent and Trademark Office states: "Disclosed herein are tools for repairing articular surfaces repair materials and for repairing an articular surface. The surgical tools are designed to be customizable or highly selectable by patient to increase the speed, accuracy and simplicity of performing total or partial arthroplasty."
The patent application was filed on May 10, 2010 (12/776,701). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,366,771&OS=8,366,771&RS=8,366,771
Written by Arpi Sharma; edited by Anand Kumar.
***
Vertex Pharmaceutical Assigned Patent
ALEXANDRIA, Va., Feb. 11 -- Vertex Pharmaceutical, Cambridge, Mass., has been assigned a patent (8,367,691) developed by nine co-inventors for "modulators of muscarinic receptors." The co-inventors are Lewis R. Makings, Encinitas, Calif., Miguel Garcia-Guzman Blanco, San Diego, Dennis J. Hurley, San Marcos, Calif., Ioana Drutu, La Jolla, Calif., Gabriel Raffai, Tucson, Ariz., Daniele M. Bergeron, La Mesa, Calif., Akiko Nakatani, San Diego, Andreas P. Termin, Encinitas, Calif., and Alina Silina, San Diego.
The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention relates to modulators of muscarinic receptors. The present invention also provides compositions comprising such modulators, and methods therewith for treating muscarinic receptor mediated diseases."
The patent application was filed on June 4, 2010 (12/794,202). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,67,691.PN.&OS=PN/83,67,691&RS=PN/83,67,691
Written by Amal Ahmed; edited by Jaya Anand.
***
Valeant Pharmaceuticals International Assigned Patent
ALEXANDRIA, Va., Feb. 11 -- Valeant Pharmaceuticals International, Aliso Viejo, Calif., has been assigned a patent (8,367,684) developed by Jean-Michel Vernier, Laguna Niguel, Calif., Samedy Ouk, Los Angeles, and Martha A. De La Rosa, San Diego, for "derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators."
The abstract of the patent published by the U.S. Patent and Trademark Office states: "This invention provides potassium channel modulators which are compounds of formula I ##STR00001## where at least one of W and Z is N; where the moiety ##STR00002## is one of Groups A or B below A ##STR00003## where Ar is a 1,2-fused, six membered ring aromatic group, bearing substituents R.sub.1 and R.sub.2 as defined below, and containing zero or one ring nitrogen atom; and where other substituents are defined herein. The invention also provides a composition comprising a pharmaceutically acceptable carrier and at least one of the following: i) a pharmaceutically effective amount of a compound of formula I and ii) a pharmaceutically acceptable salt, ester, or prodrug thereof. The invention also provides a method of preventing or treating a disease or disorder which is affected by activities of potassium channels, comprising administering to a patient in need thereof a therapeutically effective amount of a compound of formula I or a salt, ester, or prodrug thereof."
The patent application was filed on June 12, 2008 (12/138,251). The full
For more information about Targeted News Service products and services, please contact: Myron Struck, editor, Targeted News Service LLC, Springfield, Va., 703/304-1897; editor@targetednews.com; http://targetednews.com.
-1114017
(c) 2013 Targeted News Service
[ Back To TMCnet.com's Homepage ]
|
Call Center/CRM
Info Tech 
IP Communications 
Mobile 
Green 
Satellite 
Robotics 
Internet Telephony Magazine
Click here to read latest issue
CUSTOMER 
Cloud Computing Magazine
Click here to read latest issue
M2M Evolution Magazine
